Association of serum procalcitonin level with acute respiratory distress syndrome in patients following cardiopulmonary bypass
DOI:
https://doi.org/10.18203/2349-2902.isj20243541Keywords:
Serum procalcitonin level, Acute respiratory distress syndrome, Association, Cardiopulmonary bypassAbstract
Background: Acute respiratory distress syndrome is a potentially life-threatening complication after cardiac surgery. Systemic inflammatory response is activated during cardiopulmonary bypass time which may cause acute respiratory distress syndrome and serum procalcitonin level also increases during systemic inflammatory response. This study aimed to see the association of serum procalcitonin level with acute respiratory distress syndrome in patients following cardiopulmonary bypass.
Methods: This was a prospective observational study conducted in the Department of Cardiac Surgery, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh during the period from September, 2020 to August, 2022. In our study, we included 140 patients who underwent cardiac surgery with cardiopulmonary bypass. Patients were divided into two groups- group A included 70 patients with serum procalcitonin levels <7 ng/ml and group B included 70 patients with serum procalcitonin levels>7 ng/ml.
Results: The mean (±SD) age of the patients was 43.20 (±13.18) years and 46.61 (±13.75) years in group A and group B respectively. In group A, 41.4% of patients were male and 58.6% were female; in group B, 52.9% were male and 47.1% were female. On 1st postoperative day, in group, A serum procalcitonin levels were 1.36(±0.97) ng/ml and in group B serum procalcitonin levels were 27.09(±26.11) ng/ml (p<0.001). The incidence of ARDS was significantly higher in group B than in group A (35.7% versus 8.5%, p= 0.002).
Conclusion: This study concluded that there was an association of serum procalcitonin level with acute respiratory distress syndrome in patients following cardiopulmonary bypass.
References
Chen H, Cheng ZB, Yu RG. Procalcitonin as a predictor of moderate to severe acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass: a study protocol for a prospective cohort study. BMJ open. 2014;4(10):6344.
Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. British J Anaest. 1999;83(4):602-7.
Sanfilippo F, Palumbo GJ, Bignami E, Pavesi M, Ranucci M, Scolletta S, et al. acute respiratory distress syndrome in the perioperative period of cardiac surgery: predictors, diagnosis, prognosis, management options, and future directions. J Cardiothor Vasc Anest. 2022;36(4):1169-79.
Song JH, Woo WK, Song SH, Kim HH, Kim BJ, Kim HE, et al. Outcome of veno-venous extracorporeal membrane oxygenation use in acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass. Journal of Thoracic Disease. 2016;8(7):1804.
Milot J, Perron J, Lacasse Y, Létourneau L, Cartier PC, Maltais F. Incidence and predictors of ARDS after cardiac surgery. Chest. 2001;119(3):884-8.
Ranieri VM, Rubenfeld GD, Taylor Thompson B, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA: J American Med Assoc. 2012;307:23.
Rong LQ, Di Franco A, Gaudino M. Acute respiratory distress syndrome after cardiac surgery. Journal of thoracic disease. 2016;8(10):1177.
Soreng K, Levy HR. Procalcitonin: an emerging biomarker of bacterial sepsis. Clinical microbiology newsletter. 2011;33(22):171-8.
Kallel S, Jmel W, Jarraya A, Abdenadher M, Frikha I, Karouia A. The role of procalcitonin and N-terminal pro-B-type natriuretic peptide in predicting outcome after cardiac surgery. Perfusion. 2012;27(6):504-11.
Assicot M, Bohuon C, Gendrel D, Raymond J, Carsin H, Guilbaud JJ. High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet. 1993;341(8844):515-8.
Prat C, Ricart P, Ruyra X, Domínguez J, Morillas J, Blanco S, et al. Serum concentrations of procalcitonin after cardiac surgery. J Cardiac Surg. 2008;23(6):627-32.
Kilger E, Pichler B, Goetz AE, Rank N, Welte M, Morstedt K, et al. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg. 1998;46:130-3.
Cheng ZB, Chen H. Higher incidence of acute respiratory distress syndrome in cardiac surgical patients with elevated serum procalcitonin concentration: a prospective cohort study. Eur J Med Res. 2020;25:1-8.
Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Int Care Med. 2002;28:1094-102.
Chen SW, Chang CH, Chu PH, Chen TH, Wu VC, Huang YK, et al. Risk factor analysis of postoperative acute respiratory distress syndrome in valvular heart surgery. J Cri Care. 2016;31(1):139-43.
Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations after different types of surgery. Intensive Care Med. 1998;24:680–4.
Boeken U, Feindt P, Petzold T. Diagnostic value of procalcitonin: the influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis. Thorac Cardiovasc Surg. 1998;46:348–51.
Dandona P, Nix D, Wilson MF. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–8.
Fransen E, Maessen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest. 1998;111:1290–5
Hensel M, Volk T, Docke WD. Hyperprolactinemia in patients with non-infectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiol. 1998;89:93–104.
